Your browser doesn't support javascript.
loading
Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study.
Auth, Marcus Karl-Heinz; Ashton, James John; Jones, Kelsey D J; Rodrigues, Astor; Thangarajah, Dhamyanthi; Devadason, David; Lee, Gemma; Ayaz, Mashhood; Lee, Huey Miin; Kammermeier, Jochen.
Afiliação
  • Auth MK; Department of Paediatric Gastroenterology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK marcus.auth@alderhey.nhs.uk.
  • Ashton JJ; Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
  • Jones KDJ; Department of Paediatric Gastroenterology, Southampton Children's Hospital, Southampton, UK.
  • Rodrigues A; Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK.
  • Thangarajah D; Department of Paediatric Gastroenterology, Great Ormond Street Hospital, London, UK.
  • Devadason D; Department of Paediatric Gastroenterology, University of Oxford, Oxford, UK.
  • Lee G; Paediatric Gastroenterology, John Radcliffe Hospital, Oxford, UK.
  • Ayaz M; Department of Paediatric Gastroenterology, Chelsea and Westminster Hospital, London, UK.
  • Lee HM; Paediatric Gastroenterology, Nottingham Children's Hospital, Nottingham, UK.
  • Kammermeier J; Department of Paediatric Gastroenterology, Evelina London Children's Hospital, London, UK.
Arch Dis Child ; 108(12): 994-998, 2023 12.
Article em En | MEDLINE | ID: mdl-37541682

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Ustekinumab Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Ustekinumab Idioma: En Ano de publicação: 2023 Tipo de documento: Article